Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate.
Journal: Current medical research and opinion
Published: May 16, 2022
Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations.
Journal: Drugs in R&D
Published: March 05, 2020
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects.
Journal: Advances in therapy
Published: January 17, 2020
A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects.
Journal: Cancer chemotherapy and pharmacology
Published: January 08, 2020
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects.
Journal: The Journal of antimicrobial chemotherapy
Published: December 18, 2019
Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort Study.
Journal: Alcoholism, clinical and experimental research
Published: November 12, 2019
Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study.
Journal: Pain medicine (Malden, Mass.)
Published: September 26, 2019
Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users.
Journal: Pain medicine (Malden, Mass.)
Published: April 16, 2019
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Journal: Addiction biology
Published: January 14, 2019
Abuse potential of mirogabalin in recreational polydrug users.
Journal: Therapeutic advances in drug safety
Published: January 04, 2019
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 02, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.
Journal: Journal of clinical pharmacology
Published: June 04, 2018
Last Updated: 09/26/2026